Henry Schein(HSIC) zacks.com·2024-05-20 14:56Group 1 - Zacks Premium offers various tools for investors to enhance their stock market confidence and investment strategies, including daily updates, research reports, and stock screens [1][2] - The Zacks Style Scores categorize stocks based on value, growth, and momentum characteristics, providing ratings from A to F to indicate potential performance [2][3] Group 2 - The Value Score identifies attractive stocks using financial ratios like P/E and Price/Sales, appealing to value investors seeking undervalued opportunities [3] - The Growth Score focuses on a company's future prospects by analyzing earnings, sales, and cash flow, targeting growth investors [4] - The Momentum Score helps investors capitalize on price trends by assessing recent price changes and earnings estimate shifts [5] Group 3 - The VGM Score combines all three Style Scores, offering a comprehensive view for investors who utilize multiple investing strategies [6] - The Zacks Rank, based on earnings estimate revisions, has shown strong historical performance, with 1 (Strong Buy) stocks averaging a +25.41% annual return since 1988 [7][8] Group 4 - For optimal returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B, maximizing the probability of success [9] - Stocks with lower ranks but high Style Scores may still face downward price pressure if earnings outlooks are negative [10] Group 5 - Henry Schein Inc. (HSIC) is a leading global distributor of health care products, serving various practitioners and operating in 33 countries [11] - HSIC currently holds a 3 (Hold) Zacks Rank with a VGM Score of A and a Momentum Style Score of B, having seen a 5.3% increase in shares over the past month [11][12] - Analysts have revised HSIC's earnings estimate upwards, with the Zacks Consensus Estimate increasing by 5.08 per share, indicating a solid investment opportunity [12]